Larvol Delta - CanariaBio-Achieves-Signicant-Milestone-with-FDA39s-Orphan-Drug-Designation-for-MAbAR205-Targeting-Pancreatic-Cancer

BrevaRex (AR20.5) - CanariaBio

https://www.prnewswire.com/news-releases/canariabio-achieves-significant-milestone-with-fdas-orphan-drug-designation-for-mab-ar20-5-targeting-pancreatic-cancer-301905407.html

Aug 21, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next